Reboxetine Mesilate

甲磺酸瑞波西汀

Report date: 2023/02/08 16:34:15
NME

Base Information

Drug NameReboxetine Mesilate
Drug Alias NamereboxetinumreboxetinaSolvexVestraEdronax +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine transporter inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsDepressive Disorder
Approved Indications in ChinaDepressive Disorder
Original Approved Country/TerritoryUnited Kingdom of Great Britain and Ireland
Original Approved Date1997/10/07
Country/TerritoryUnited Kingdom of Great Britain and IrelandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesYaopharma Co LtdPharmacia Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN06AX18
Related LinksWikipediaDrugBankKEGG